Resultats globals: 1 registres trobats en 0.02 segons.
Articles, 1 registres trobats
Articles 1 registres trobats  
1.
9 p, 821.4 KB Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma : Final Results of a Randomized Phase III Study / Kwak, Larry W. (Comprehensive Cancer Center, Duarte) ; Sancho, Juan Manuel (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Cho, Seok Goo (The Catholic University of Korea, Seoul, South Korea) ; Nakazawa, Hideyuki (Shinshu University School of Medicine, Nagano, Japan) ; Suzumiya, Junji (Shimane University Hospital, Innovative Cancer Center/Oncology-Hematology, Izumo, Japan) ; Tumyan, Gayane (Division of Hematology and Bone Marrow Transplantation, Blokhin Russian Cancer) ; Kim, Jin Seok (Yonsei University College of Medicine, Severance Hospital, Seoul, South Korea) ; Menne, Tobias (Newcastle University, UK) ; Mariz, José (Instituto Português de Oncología do Porto) ; Ilyin, Nikolai (Ministry of Health of the Russian Federation) ; Jurczak, Wojciech (Maria Sklodowska-Curie National Research Institute of Oncology, Kraków, Poland) ; Lopez Martinez, Aurelio (Hospital Arnau de Vilanova (València)) ; Samoilova, Olga (Nizhniy Novgorod Region Clinical Hospital, Nizhniy Novgorod, Russia) ; Zhavrid, Edvard (N. N. Alexandrov Republican Scientific and Practical Centre of Oncology and Medical Radiology, Belarus) ; Yañez Ruiz, Eduardo (Universidad de la Frontera, Temuco, Chile) ; Trneny, Marek (Charles University, Czech Republic) ; Popplewell, Leslie (Toni Stephenson Lymphoma Cancer Center and Department of Hematology and Hematopoietic Cell Transplantation, Duarte, CA) ; Ogura, Michinori (Kasugai Municipal Hospital, Aichi 486-8510, Japan.) ; Kim, Wong Seog (Sungkyunkwan University School of Medicine, Seoul, South Korea) ; Lee, Sang Joon (Celltrion. Inc, South Korea) ; Kim, Sung Hyun (Celltrion. Inc, South Korea) ; Ahn, Keum Young (Celltrion. Inc, South Korea) ; Buske, Christian (University Hospital of Ulm, Germany)
Introduction: This double-blind, parallel-group, active-controlled phase III trial (NCT02260804) assessed CT-P10 and rituximab safety and efficacy in patients with previously untreated low-tumor-burden follicular lymphoma (LTBFL), including after a single switch from rituximab to CT-P10. [...]
2022 - 10.1016/j.clml.2021.08.005
Clinical Lymphoma, Myeloma & Leukemia, Vol. 22 Núm. 2 (february 2022) , p. 89-97  

Vegeu també: autors amb noms similars
1 Nakazawa, H.
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.